AWCI
BLFS icon

Alpine Woods Capital Investors’s BioLife Solutions BLFS Stock Holding History

Alpine Woods Capital Investors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,900
Closed -$181K – 257
2019
Q3 		$181K Buy
10,900
+900
+9% +$16.9K 0.03% 247
2019
Q2 		$170K Buy
+10,000
New +$174K 0.04% 262

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alpine Woods Capital Investors's BLFS Position: Q4 2019 in Review

Alpine Woods Capital Investors sold out of BioLife Solutions (BLFS) in Q4 2019, closing a stake of 10,900 shares — an estimated $181K sold.

Alpine Woods Capital Investors first reported a position in BLFS in Q2 2019 and held it in 2 quarters. The position peaked at $181K in Q3 2019. 80 funds tracked by Wall St. Rank hold BLFS as of Q4 2019.

  • Alpine Woods Capital Investors reported no remaining BioLife Solutions position as of Q4 2019 after selling out during the quarter.
  • Alpine Woods Capital Investors sold 10,900 BioLife Solutions shares in Q4 2019, an estimated $181K.
  • Alpine Woods Capital Investors first reported a position in BioLife Solutions in Q2 2019 and held it in 2 quarters.
  • Alpine Woods Capital Investors's BioLife Solutions position peaked at $181K in Q3 2019.
  • 80 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2019.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2019, filed 7 Feb 2020.